Endocrine Abstracts

Introduction and Objectives: Despite the many known advantages of Flash Glucose Monitoring (FGM), very few studies have shown a real improvement in the patient’s overall quality of life. Therefore, our aim is to assess, using the validated Diabetes Mellitus Specific Quality of Life Questionnaire: Spanish version (EsDQOL), whether these differences really exist in our population.

Methods: An observational, prospective study was conducted comparing quality of life in patients with T1D prior to FGM and after 6 months of its use in a cohort of 89 patients from 1 January 2021 to 31 December 2022 employing the EsDQOL questionnaire which measures four variables: satisfaction, impact, social concern and concern about diabetes. The total score ranges from 43 to 215, with a higher score corresponding to a poorer quality of life. Kolmogorov-Smirnov test, Student’s t-test and Wilcoxon test were used.

Results: 89 patients were studied with 63% of women with a mean age of 42±14.1 years with 10.8±8.3 years of T1D evolution obtaining an improvement (P<0.05) in quality of life comparing each of the 4 items separately and globally in the questionnaire (96 [63-125] vs 79 [58-101]).

Conclusions: In addition to the already known advantages in glycaemic control variables, we can conclude that the implementation of the FGM has led to an improvement in the quality of life of our patients with T1D, reducing their concerns about social and occupational aspects and about the future effects of diabetes while improving the impact and satisfaction with the treatment received.